Expert Interview
A Third Look: Discussing the investigational RNAi therapeutic in development by Arrowhead Pharmaceuticals, plozasiran (ARO-APOC3), and their Phase 2b data presented at ACC 2024.
Ticker(s): ARWRInstitution: LakeView Healthcare System
- Cardiologist who sees over 100 patients on anticoagulation medications
- Medical School: M.D Albert Einstein College of Medicine. Residency: Hospital of the Albert Einstein College of Medicine Fellowship: Albert Einstein College of Medicine
- Research interest in cardiac problems during pregnancy
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
